BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 218432)

  • 1. Regulation of insulin receptors in normal and abnormal physiology in humans.
    Bar RS; Harrison LC; Muggeo M; Gorden P; Kahn CR; Roth J
    Adv Intern Med; 1979; 24():23-52. PubMed ID: 218432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptor status in disease states of man.
    Bar RS; Roth J
    Arch Intern Med; 1977 Apr; 137(4):474-81. PubMed ID: 192162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin receptors and syndromes of insulin resistance.
    Kahn CR
    Diabetes Care; 1982; 5 Suppl 1():98-101. PubMed ID: 6765124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin receptors and their research significance in the diagnosis of carbohydrate metabolic disorders (a review of the literature)].
    Balabolkin MI; Nedosugova LV
    Lab Delo; 1980; (7):404-9. PubMed ID: 6157866
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.
    Kahn CR; Baird K; Filier JS; Jarrett DB
    J Clin Invest; 1977 Nov; 60(5):1094-106. PubMed ID: 908753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-resistant diabetes mellitus and insulin receptor antibodies: variable association with acanthosis nigricans.
    Goldman J
    Henry Ford Hosp Med J; 1980; 28(2-3):161-7. PubMed ID: 7287512
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.
    Bar RS; Gorden P; Roth J; Kahn CR; De Meyts P
    J Clin Invest; 1976 Nov; 58(5):1123-35. PubMed ID: 993336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypeptide hormones: pathology and clinical aspects.
    Van Obberghen E
    Acta Histochem Suppl; 1984; 29():51-5. PubMed ID: 6425926
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin receptor and postreceptor disorders: significance for the development and therapy of carbohydrate metabolic disorders].
    Schernthaner G; Prager R
    Acta Med Austriaca; 1984; 11(3-4):70-8. PubMed ID: 6382903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperinsulinism syndromes caused by insulin resistance].
    Robert JJ
    Ann Pediatr (Paris); 1990 Mar; 37(3):143-9. PubMed ID: 2190520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin receptors].
    Mosora N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):311-7. PubMed ID: 6120547
    [No Abstract]   [Full Text] [Related]  

  • 14. Guanine nucleotide binding regulatory proteins in liver from obese humans with and without type II diabetes: evidence for altered "cross-talk" between the insulin receptor and Gi-proteins.
    Caro JF; Raju MS; Caro M; Lynch CJ; Poulos J; Exton JH; Thakkar JK
    J Cell Biochem; 1994 Mar; 54(3):309-19. PubMed ID: 8200911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New data in the domain of insulin resistance].
    Freychet P
    Sem Hop; 1977 Jun; 53(24):1421-4. PubMed ID: 197631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Receptor dysfunction as a pathogenetic principle in hormone resistance and metabolic diseases].
    Tenschert W; Vetter H; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1981 Feb; 111(6):174-81. PubMed ID: 6261324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies.
    Gerozissis K
    Eur J Pharmacol; 2008 May; 585(1):38-49. PubMed ID: 18407262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are insulin receptors clinically significant?
    Seltzer HS
    J Lab Clin Med; 1982 Dec; 100(6):815-21. PubMed ID: 7142787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic tolbutamide administration on normal and obese-hyperglycemic mice: evidence for post-receptor potentiation of insulin action.
    Poyet C; Feldman JM
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):355-76. PubMed ID: 7043679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.